OPTI-EXPRESSION Trademark

Trademark Overview

On Thursday, December 13, 2018, a trademark application was filed for OPTI-EXPRESSION with the United States Patent and Trademark Office. The USPTO has given the OPTI-EXPRESSION trademark a serial number of 88227908. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Wednesday, May 14, 2025. This trademark is owned by BioIVT Holdings, LLC. The OPTI-EXPRESSION trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific research in the field of life science; pharmaceutical research services, namely, pharmaceutical drug development services
opti-expression

General Information

Serial Number88227908
Word MarkOPTI-EXPRESSION
Filing DateThursday, December 13, 2018
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateWednesday, May 14, 2025
Registration Number5825612
Registration DateTuesday, August 6, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 21, 2019

Trademark Statements

Goods and ServicesScientific research in the field of life science; pharmaceutical research services, namely, pharmaceutical drug development services

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, January 5, 2019
Primary Code042
First Use Anywhere DateSunday, February 15, 2009
First Use In Commerce DateSunday, February 15, 2009

Trademark Owner History

Party NameBioIVT Holdings, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressWestbury, NY 11590
Party NameBioIVT Holdings, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressWilmington, DE 19808
Party NameBioIVT Holdings, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressWilmington, DE 19808

Trademark Events

Event DateEvent Description
Monday, December 17, 2018NEW APPLICATION ENTERED
Saturday, January 5, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, March 12, 2019NON-FINAL ACTION WRITTEN
Tuesday, March 12, 2019NON-FINAL ACTION E-MAILED
Tuesday, March 12, 2019ASSIGNED TO EXAMINER
Tuesday, March 12, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, April 13, 2019LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, May 21, 2019PUBLISHED FOR OPPOSITION
Tuesday, May 21, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Saturday, March 16, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 18, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, March 16, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, March 29, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, April 13, 2019ASSIGNED TO LIE
Wednesday, May 1, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 27, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, September 27, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, September 27, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, September 27, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, August 6, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, January 17, 2025TEAS SECTION 8 & 15 RECEIVED
Tuesday, August 6, 2019REGISTERED-PRINCIPAL REGISTER
Tuesday, September 27, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, May 12, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, May 14, 2025NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Friday, September 19, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, September 19, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, September 19, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, May 14, 2025REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

Related Keywords

expression opti pharmaceutical services research namely development drug science field life scientific